Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies into Clinical Development

Hustle engaged FLG when we started scaling rapidly after our Series B. Patty Fukami joined our team and seemingly overnight leveled up our entire Finance operation, including accounting, billing, and FP&A. Beyond that, she has been a true partner to me as CEO in growing the business and has become a highly respected leader at the company, shifting Hustle’s entire culture to be more financially prudent and to make better decisions for the long-term financial health of the business.